Blood-based biomarkers of amyloid pathology and neurodegeneration are entering clinical use. It is critical to understand what factors affect the levels of these markers.

中文翻译：

---

淀粉样蛋白和神经退行性血浆生物标志物与合并症的关联


淀粉样蛋白病理学和神经变性的血液生物标志物正在进入临床应用。了解哪些因素影响这些标记物的水平至关重要。